OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Sentiment Mix
Geography
Expert Signals
TechCrunch - AI
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B.
Supported by 1 story
Lightspeed is in discussions to lead the funding round, sources say.
Supported by 1 story
Related Events
Breaking: China’s DeepSeek AI Eyes IPO To Rival OpenAI, Anthropic, SpaceX - Cryptonews.net
LLMs • 7/15/2026
69% of Americans want AI giants like OpenAI and Anthropic to give up half their stock to a public wealth fund - Yahoo Finance
LLMs • 7/14/2026
GoML Announces New Enterprise Business Line for Claude Developers - AiThority
LLMs • 7/14/2026
Microsoft Adds Anthropic AI to Copilot - GuruFocus
LLMs • 7/15/2026
Meta’s Adam Mosseri says AI token budgets could soon be capped per engineer - Yahoo Finance
LLMs • 7/15/2026
Causality Chain
Preceded By
GoML Announces New Enterprise Business Line for Claude Developers - AiThority
70 causal score
Anthropic releases unsettling ad that showcases AI in everyday life - Межа. Новини України.
63 causal score
Breaking: China’s DeepSeek AI Eyes IPO To Rival OpenAI, Anthropic, SpaceX - Cryptonews.net
60 causal score